scispace - formally typeset
O

Olivier Ethgen

Researcher at University of Liège

Publications -  89
Citations -  4944

Olivier Ethgen is an academic researcher from University of Liège. The author has contributed to research in topics: Population & Cost effectiveness. The author has an hindex of 28, co-authored 78 publications receiving 4495 citations. Previous affiliations of Olivier Ethgen include World Health Organization.

Papers
More filters
Journal ArticleDOI

Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature.

TL;DR: Overall, total hip and total knee arthroplasties were found to be quite effective in terms of improvement in health-related quality-of-life dimensions, with the occasional exception of the social dimension.
Journal ArticleDOI

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis: A Comprehensive Meta-analysis

TL;DR: This study demonstrates the structural efficacy of glucosamine and indistinguishable symptomatic efficacies for both compounds in knee osteoarthritis and further studies are needed to investigate the relationship among time, dose, patient baseline characteristics, and structural efficacy for an accurate, disease-modifying characterization of these 2 compounds.
Journal ArticleDOI

Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents

TL;DR: Bruyere et al. as discussed by the authors investigated the effects of whole body vibration in the elderly and found that the vibration intervention can improve elements of fall risk and health-related quality of life in elderly patients.
Journal ArticleDOI

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach.

TL;DR: This meta-analysis characterised the "compound" and "time" aspects of the GI toxicity of non-selective NSAIDs and the risk/benefit ratio of such compounds should thus be carefully and individually evaluated at the start of long term treatment.
Journal ArticleDOI

The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action.

TL;DR: It is shown that the number of sarcopenic patients will dramatically increase in the next 30 years, making consequences of muscle wasting a major public health issue.